Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MONOBODY AND NK CELLS
Document Type and Number:
WIPO Patent Application WO/2024/048575
Kind Code:
A1
Abstract:
The present invention provides a novel substance that stably binds to a surface protein which is expressed in NK cells. The present invention provides a monobody that binds to a surface protein of NK cells and that has any one of amino acid sequences (1) to (3): (1) an amino acid sequence represented by any one of SEQ ID NOs: A1-A12; (2) an amino acid sequence in which, in an amino acid sequence represented by any one of SEQ ID NOs: A1-A12, a deletion, substitution, and/or addition of one or more amino acids is made to an amino acid sequence other than an arbitrary amino acid; and (3) an amino acid sequence having not less than 80% sequence identity with an amino acid sequence other than an arbitrary amino acid sequence, in the amino acid sequence represented by any one of SEQ ID NOs: A1-A12 (in SEQ ID NOs: A1-A12, X1, X2, X3, X4, X5 and X6 are each independently an arbitrary amino acid, and n1, n2, n3, n4, n5 and n6 each independently represent an arbitrary natural number).

Inventors:
HARADA YUI (JP)
YONEMITSU YOSHIKAZU (JP)
MURAKAMI HIROSHI (JP)
HAYASHI GOSUKE (JP)
FUJINO TOMOSHIGE (JP)
TANAKA CHIHIRO (JP)
Application Number:
PCT/JP2023/031204
Publication Date:
March 07, 2024
Filing Date:
August 29, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GAIA BIOMEDICINE INC (JP)
International Classes:
C12N15/13; C07K16/28; C12N5/0783
Domestic Patent References:
WO2021212638A12021-10-28
Foreign References:
US20220135678A12022-05-05
Attorney, Agent or Firm:
INABA, Yoshiyuki et al. (JP)
Download PDF: